Skip to main navigation
Leap therapeutics
Leap therapeutics
  • About
    • About
    • Contact Us
  • Pipeline
    • Pipeline
    • Sirexatamab (DKN-01) Programs
      • Gastric Cancer
      • Colorectal Cancer
      • Endometrial Cancer
      • Prostate Cancer
      • Lung Cancer
    • FL-501 Program
  • Science
    • Science
    • DKK1
    • Sirexatamab (DKN-01)
    • GDF15
  • Patients
    • Patients
    • Expanded Access
  • Careers
  • Investors
    • Investors
    • Stock Information
    • News Releases
    • Presentations & Events
    • Financial Information
    • Information Request

News
Releases

image description

News Releases

Aug 18, 2026
Cypherpunk Technologies Launches World's Largest Zcash Mining Fleet
Aug 12, 2026
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
Aug 12, 2026
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
  • image Print Page Print Page
  • image Email Alerts Email Alerts
  • image Contact Us Contact Us
image description
image description
Leap therapeutics
47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA
+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

  • ABOUT
  • CONTACT US
  • CAREERS
  • PIPELINE
  • Sirexatamab (DKN-01) Programs
  • FL-501 Program
  • PATIENTS
  • EXPANDED ACCESS
  • SCIENCE
  • DKK1
  • Sirexatamab (DKN-01)
  • GDF-15
  • INVESTORS
  • STOCK INFORMATION
  • NEWS RELEASES
  • PRESENTATIONS & EVENTS
  • FINANCIAL INFORMATION
  • INFORMATION REQUEST
  • © 2026 Leap Therapeutics, Inc.
  • All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Cookie Policy